Clinical Trial Update: Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ZM001 injection in refractory systemic lupus erythematosus; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• ZM001 (ZM001)

Snippet

Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: NOT_YET_RECRUITING